Literature DB >> 21836093

The unrecognized psychosocial factors contributing to bleeding risk in warfarin therapy.

Basia Diug1, Sue Evans, Judy Lowthian, Ellen Maxwell, Michael Dooley, Alison Street, Rory Wolfe, Peter Cameron, John McNeil.   

Abstract

BACKGROUND AND
PURPOSE: Warfarin is an effective drug for the prevention of thromboembolism in the elderly. The major risk for patients taking warfarin is bleeding. We aimed to assess the impact of psychosocial factors, including mood, cognition, social isolation, and health literacy on warfarin instability among community-based elderly patients.
METHODS: A case-control study was conducted between March 2008 and June 2009 in a community-based setting. Cases were patients previously stabilized on warfarin who recorded an international normalized ratio≥6.0. Control subjects were patients whose international normalized ratio measurement was maintained within the therapeutic range. Patient interviews investigated potential predisposing factors to elevated International Normalized Ratio levels.
RESULTS: A total of 486 patients were interviewed: 157 cases and 329 control subjects, with an approximate mean age of 75 years. Atrial fibrillation was the most common primary indication. Adjusted multivariate logistic regression revealed impaired cognition (OR, 1.9; 95% CI, 1.0 to 3.6), depressed mood (OR, 2.2; 95% CI, 1.2 to 3.9), and inadequate health literacy (OR, 4.0;95% CI, 2.1 to 7.4) were associated with increased risk of an elevated International Normalized Ratio.
CONCLUSIONS: This study identified impaired cognition, depressed mood, and inadequate health literacy as risk factors for warfarin instability. These had a similar impact to well-recognized demographic, clinical, and medication-related factors and are prevalent among the elderly. These findings suggest that elderly patients prescribed warfarin should be reviewed regularly for psychosocial deficits.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21836093     DOI: 10.1161/STROKEAHA.111.615674

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

1.  The effect of cognitive impairment in the elderly on the initial and long-term stability of warfarin therapy.

Authors:  Hanan S Khreizat; Peter Whittaker; Kristy D Curtis; Gerald Turlo; Candice L Garwood
Journal:  Drugs Aging       Date:  2012-04-01       Impact factor: 3.923

Review 2.  Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project.

Authors:  Graziano Onder; Francesco Landi; Domenico Fusco; Andrea Corsonello; Matteo Tosato; Miriam Battaglia; Simona Mastropaolo; Silvana Settanni; Manuela Antocicco; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2014-01       Impact factor: 3.923

Review 3.  Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

4.  Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: The SAGE-AF study.

Authors:  Weijia Wang; Jane Saczynski; Darleen Lessard; Tanya Mailhot; Bruce Barton; Molly E Waring; Felix Sogade; Robert Hayward; Robert Helm; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2019-09-25

5.  Health literacy and warfarin therapy at two anticoagulation clinics in Brazil.

Authors:  Maria Auxiliadora Parreiras Martins; Josiane Moreira Costa; Juliana Vaz de Melo Mambrini; Antonio Luiz Pinho Ribeiro; Emelia J Benjamin; Luisa Campos Caldeira Brant; Michael K Paasche-Orlow; Jared W Magnani
Journal:  Heart       Date:  2017-03-03       Impact factor: 5.994

6.  Rationale and design of the Atrial Fibrillation health Literacy Information Technology Trial: (AF-LITT).

Authors:  Emily N Guhl; Courtney L Schlusser; Lori E Henault; Timothy W Bickmore; Everlyne Kimani; Michael K Paasche-Orlow; Jared W Magnani
Journal:  Contemp Clin Trials       Date:  2017-09-18       Impact factor: 2.226

Review 7.  Social determinants of atrial fibrillation.

Authors:  Utibe R Essien; Jelena Kornej; Amber E Johnson; Lucy B Schulson; Emelia J Benjamin; Jared W Magnani
Journal:  Nat Rev Cardiol       Date:  2021-06-02       Impact factor: 32.419

8.  Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?

Authors:  Frédéric Maes; Olivia Dalleur; Séverine Henrard; Dominique Wouters; Christophe Scavée; Anne Spinewine; Benoit Boland
Journal:  Clin Interv Aging       Date:  2014-07-15       Impact factor: 4.458

9.  Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.

Authors:  Emily C O'Brien; Sunghee Kim; Laine Thomas; Gregg C Fonarow; Peter R Kowey; Kenneth W Mahaffey; Bernard J Gersh; Jonathan P Piccini; Eric D Peterson
Journal:  J Am Heart Assoc       Date:  2016-05-04       Impact factor: 5.501

Review 10.  Relation between health literacy, self-care and adherence to treatment with oral anticoagulants in adults: a narrative systematic review.

Authors:  Ana Cristina Cabellos-García; Antonio Martínez-Sabater; Enrique Castro-Sánchez; Mari Kangasniemi; Raul Juárez-Vela; Vicente Gea-Caballero
Journal:  BMC Public Health       Date:  2018-10-04       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.